Background: TB preventive treatment (TPT) reduces morbidity and mortality among people living with HIV (PLHIV). Despite the successful scale-up of TPT in Malawi, monitoring and evaluation have been suboptimal. We utilized the Malawi Population-Based HIV Impact Assessment (MPHIA) 2020-2021 survey data to estimate TPT uptake and completion among self-reported HIV-positive persons.
Methods: We estimated the proportion of HIV-positive respondents who had ever undergone TPT, and determined the percentage of those currently on TPT who had completed more than 6 months of treatment. Bivariate and multivariable logistic regression were performed to calculate the odds ratios for factors associated with ever-taking TPT. All variables were self-reported, and the analysis was weighted and accounted for in the survey design.
Results: Of the HIV+ respondents, 38.8% (95% CI 36.4-41.3) had ever taken TPT. The adjusted odds of ever taking TPT were 8.0 and 5.2 times as high in the Central and Southern regions, respectively, compared to the Northern region; 1.9 times higher among those in the highest wealth quintile, and 2.1 times higher for those on antiretroviral therapy >10 years. Of those currently taking TPT, 56.2% completed >6 months of TPT.
Conclusion: These results suggest low TPT uptake and >6 months' completion rates among self-reported HIV+ persons. Initiatives to create demand and strengthen adherence would improve TPT uptake.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11119003 | PMC |
| http://dx.doi.org/10.5588/ijtldopen.23.0194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the Fluorination and Hydroxylation of Pore-space-partitioned Metal‒Organic Frameworks for C2H2/CH4 Separation.
Chem Asian J
January 2025
National Cheng Kung University, School of Pharmacy, No.1, University Rd., 70101, Tainan City, TAIWAN.
We report three novel pore-space-partitioned metal‒organic frameworks (MOFs) functionalized with fluorine and hydroxyl groups using 2,3,5,6-tetrafluorobenzene-1,4-dicarboxylic acid (F4-BDC) and a new ligand 3,6-difluoro-2,5-dihydroxybenzene-1,4-dicarboxylic acid (F2(OH)2-BDC) as organic building blocks, with 1,3,5-tris(4-pyridyl)-2,4,6-triazine (TPT) as pore partition agent. With the polar fluorine and hydroxyl groups and the open metal sites being blocked by TPT, moderate molecule-framework interactions can be engineered. These three isoreticular microporous frameworks Mn-TPT-BDC-F4 (NCKU-21), Mn-TPT-BDC-F2(OH)2 (NCKU-22), and Mg-TPT-BDC-F2(OH)2 (NCKU-23) (NCKU = National Cheng Kung University) exhibit distinct single-component gas adsorption behaviors.
View Article and Find Full Text PDFTuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
Drugs
December 2024
The Aurum Institute, Parktown, South Africa.
Tuberculosis (TB) is the leading cause of death from a single infectious agent. The burden is highest in some low- and middle-income countries. One-quarter of the world's population is estimated to have been infected with TB, which is the seedbed for progressing from TB infection to the deadly and contagious disease itself.
View Article and Find Full Text PDFWhy do healthcare workers refuse tuberculosis preventive treatment (TPT)? a qualitative study from Puducherry, South India.
BMJ Open Respir Res
December 2024
Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
Background: The sustainable development goal (SDG) 3.3.2 prompted India to devise the National Strategic Plan 2017-2025, targeting tuberculosis (TB) eradication by 2030.
View Article and Find Full Text PDFBurden and challenges in managing TB infection among people with occupational exposure to silica in India.
IJTLD Open
November 2024
RHTC Hospital, Ministry of Health & Family Welfare, Najafgarh, New Delhi, India.
Background: Occupational exposure to silica increases the risk of TB infection (TBI) and disease. This study aimed to determine the prevalence of TBI and explore challenges in TBI management in such individuals in two districts of India during 2023.
Methods: This was an explanatory mixed-methods study with a quantitative cohort design and qualitative descriptive in-depth interviews.
Active tuberculosis disease among people living with HIV on ART who completed tuberculosis preventive therapy at three public hospitals in Uganda.
PLoS One
November 2024
Faculty of Science and Technology, Department of Health Sciences, Cavendish University Uganda, Kampala, Uganda.
Tuberculosis (TB) preventive therapy (TPT) reduces the incidence of TB among people living with the human immunodeficiency virus (PLHIV). However, despite an increase in TPT uptake, TB/HIV coinfection remains stagnant in Uganda especially in areas of increasing HIV incidence such as the Bunyoro sub-region. This study was a retrospective review records (antiretroviral therapy [ART] files) of PLHIV who were active on ART and completed TPT in 2019/2020 at three major hospitals in the Bunyoro sub-region, Uganda: Masindi General Hospital, Hoima Regional Referral Hospital, and Kiryandongo General Hospital.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!